QingSong Health Corporation (HKG:2661)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
160.90
+10.70 (7.12%)
At close: Mar 27, 2026

QingSong Health Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
1,256945.01489.96393.61
Revenue Growth (YoY)
32.90%92.87%24.48%-
Cost of Revenue
820.74583.3898.4968.44
Gross Profit
435.14361.63391.48325.16
Selling, General & Admin
285.79227.04187.1125.61
Research & Development
75.5972.0461.3952.82
Other Operating Expenses
-3.03--
Operating Expenses
361.62302.15248.78178.62
Operating Income
73.5259.48142.7146.54
Interest & Investment Income
6.7110.879.078.44
Currency Exchange Gain (Loss)
-0.03-1.83-2.39-10.01
Other Non Operating Income (Expenses)
-55.56-11.1607
EBT Excluding Unusual Items
24.6557.36149.38151.97
Gain (Loss) on Sale of Investments
0.890.123.55
Gain (Loss) on Sale of Assets
-0.28-0.05-
Other Unusual Items
-404.42-50.37-48.3-150.63
Pretax Income
-378.887.38104.546.34
Income Tax Expense
0.85-1.617.3715.44
Earnings From Continuing Operations
-379.728.9997.17-9.1
Earnings From Discontinued Operations
-1.41-23.527.04
Net Income
-379.7210.473.65-2.06
Net Income to Common
-379.7210.473.65-2.06
Net Income Growth
--85.88%--
Shares Outstanding (Basic)
83808080
Shares Outstanding (Diluted)
8310120280
Shares Change (YoY)
-17.96%-50.09%152.68%-
EPS (Basic)
-4.580.130.92-0.03
EPS (Diluted)
-4.580.110.60-0.03
EPS Growth
--81.09%--
Free Cash Flow
82.0982.797.6557.2
Free Cash Flow Per Share
0.990.820.040.71
Gross Margin
34.65%38.27%79.90%82.61%
Operating Margin
5.85%6.29%29.13%37.23%
Profit Margin
-30.23%1.10%15.03%-0.52%
Free Cash Flow Margin
6.54%8.76%1.56%14.53%
EBITDA
7459.7142.99146.99
EBITDA Margin
5.89%6.32%29.18%37.34%
D&A For EBITDA
0.470.230.290.45
EBIT
73.5259.48142.7146.54
EBIT Margin
5.85%6.29%29.13%37.23%
Effective Tax Rate
--7.05%243.52%
Advertising Expenses
-129.31107.0448.15
Source: S&P Global Market Intelligence. Standard template. Financial Sources.